AFP and hepatocellular carcinoma: In summary, using a novel screening method based on a large cohort of subjects, a panel of seven anti-TAA autoantibodies as biomarkers were identified and validated, which can provide a far-reaching approach in the detection of HCC, especially for AFP-negative HCC.